(Q44198859)

30 November 2017

title

Possible benefits of high-dose chemotherapy and autologous stem cell transplantation for adults with recurrent medulloblastoma (English)

1 reference

30 November 2017

0 references

1 reference

Zia MI

1

1 reference

30 November 2017

Forsyth P

2

1 reference

30 November 2017

Chaudhry A

3

1 reference

30 November 2017

Russell J

4

1 reference

30 November 2017

Stewart DA

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Bone Marrow Transplantation

30 November 2017

published in

1 reference

30 November 2017

volume

30

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

565-569

1 reference

Surveillance scanning of children with medulloblastoma.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Cisplatin in the treatment of recurrent childhood primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Carboplatin and recurrent childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Response of recurrent medulloblastoma to low-dose oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Improvement in survival produced by sequential therapies in the treatment of recurrent medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Medulloblastoma in adults: clinical characteristics and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

A phase II evaluation of thiotepa in pediatric central nervous system malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703725

21 January 2018

Identifiers

DOI

10.1038/SJ.BMT.1703725

1 reference

30 November 2017

1 reference